Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28.
about
P1343
Exon shuffling in vivo can generate novel HLA class I moleculesPatients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 moleculesQuantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramersMolecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognitionPoor binding of a HER-2/neu epitope (GP2) to HLA-A2.1 is due to a lack of interactions with the center of the peptideMolecular characterization of HLA class I in Colombians carrying HLA-A2: high allelic diversity and frequency of heterozygotes at the HLA-B locusThe oxidoreductase ERp57 efficiently reduces partially folded in preference to fully folded MHC class I moleculesPhosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivoPillars article: Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 1992. 255: 1261-1263.Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy.Measurement of two-dimensional binding constants between cell-bound major histocompatibility complex and immobilized antibodies with an acoustic biosensorThe binding of TAPBPR and Tapasin to MHC class I is mutually exclusive.In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS.CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopesC19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients.HIV-1 Nef targets MHC-I and CD4 for degradation via a final common beta-COP-dependent pathway in T cells.HLA Class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease.The human HLA-A*0201 allele, expressed in hamster cells, is not a high-affinity receptor for adenovirus type 5 fiberAmino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicityPromiscuous binding of invariant chain-derived CLIP peptide to distinct HLA-I molecules revealed in leukemic cells.Chagasic patients are able to respond against a viral antigen from influenza virus.Identifying source proteins for MHC class I-presented peptides.Rational design of nonnatural peptides as high-affinity ligands for the HLA-B*2705 human leukocyte antigenNef-mediated disruption of HLA-A2 transport to the cell surface in T cellsADP ribosylation factor 1 activity is required to recruit AP-1 to the major histocompatibility complex class I (MHC-I) cytoplasmic tail and disrupt MHC-I trafficking in HIV-1-infected primary T cells.Yersinia enterocolitica serotype O:3 alters the expression of serologic HLA-B27 epitopes on human monocytes.A Versatile Simple Capture Assay for Assessing the Structural Integrity of MHC Multimer Reagents.Early region 3 of adenovirus type 19 (subgroup D) encodes an HLA-binding protein distinct from that of subgroups B and CIdentification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus.HIV-1 Nef-induced down-regulation of MHC class I requires AP-1 and clathrin but not PACS-1 and is impeded by AP-2.Promiscuous Recognition of a Trypanosoma cruzi CD8+ T Cell Epitope among HLA-A2, HLA-A24 and HLA-A1 Supertypes in Chagasic Patients.Roles of the six peptide-binding pockets of the HLA-A2 molecule in allorecognition by human cytotoxic T-cell clones.Dynamics of major histocompatibility complex class I association with the human peptide-loading complex.Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2)Detection of shared MHC-restricted human melanoma antigens after vaccinia virus-mediated transduction of genes coding for HLAHIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail.HLA antigen structural gene mutants selected with an allospecific monoclonal antibody.HLA-A2 mutants immunoselected in vitro. Definition of residues contributing to an HLA-A2-specific serological determinant.Analysis of physical interactions between peptides and HLA molecules and application to the detection of human immunodeficiency virus 1 antigenic peptides
P2860
Q24555794-58C25E9E-F7B2-4E1F-86D9-9AF617A35618Q27478466-5A2D6A76-D03B-40CE-AF29-4C816B5F48AEQ27485114-EBE5F720-D811-4B2F-8139-FBE59A9028F6Q27485138-D7D8F7D8-0B18-4989-8F1E-FCAE26F64BF5Q27620636-20B1893B-99D2-4C70-9E8A-612968FC7F7CQ28138853-58D534B2-2181-4A7F-8F2D-5F0E5D337EF3Q28571309-486A086D-2992-4523-9CD3-07F318A1CCCFQ30306583-9010E5D6-B071-4F43-8AB0-A61D74391997Q30370319-BDB12520-174F-44FF-A9D6-9B7605AAC148Q30441689-FE1DFB5B-8373-42D7-A97E-4DDF21A75AB7Q30485325-E93A759C-3D8C-4CC2-AAF8-51538E234BFEQ30668568-C8022E2F-33AB-4590-8A52-1EB3F483DB70Q33178945-B932EE97-D747-4E96-A544-EA59A020CA66Q33222048-D1F06FC1-43C3-47DB-BF34-D647086F1DB6Q33252349-8A927114-F331-4F17-894E-EE9BACDFB0DBQ33359498-1786F1F1-1316-4C38-95FA-534903EE59BEQ33363091-2DDDC771-54AD-43EC-8672-ABCE5E27EA52Q33375075-54002585-1D89-4098-B93B-A07FFF8E37F8Q33651315-4833A20C-A163-41C7-84DE-5A3EAFA38F14Q33952895-3FBEB7BF-BB3B-483A-BFB9-43D9163A6A00Q34259644-5083583A-404A-4FB0-8676-92E18949D006Q34392873-AC18994F-7429-4E7C-9B19-9B3DEA7BDC32Q34553385-1F979E52-7236-499E-8743-D1D4F4FF4A50Q34727706-1C26B5C8-FC86-40BF-BAA6-5A499627F489Q34755576-E06F618E-E1E3-47E8-88F8-54E8F8974365Q35531422-E212F977-D998-4754-A8C0-A707165ACB5AQ35548458-9250CB35-33BD-4539-87DB-A8E503C74BA3Q35781790-7F7049C9-70DC-4E6E-9DB0-2636CD444D78Q35859922-9070B224-93AE-4D4D-AD0D-33C8154744F3Q35906814-9CC818F4-8558-40E4-93ED-5E97FAE36953Q35949112-FE05795B-76F6-4BFE-B9FA-86CA9FF216DFQ35955948-BC5DCFFC-FF9D-4B4C-9A30-30C7F99B9EF0Q36067021-39425BEE-A38D-4E95-8B12-0E0D3B6E5CC4Q36225733-38FC8776-DF80-4BA2-BABE-3DEC2A65C92AQ36231811-99951D7E-E6B0-45E0-9495-821BE595F90AQ36238343-578022D6-A3E1-4E6B-8520-66690AF84DB5Q36322591-150CF2E2-A814-4AB8-BFEF-EDA6A2718B9FQ36327363-B41E6F8C-1A0F-4FCD-AD1A-C86252EF217EQ36347388-E32267D2-B5DF-40A7-8450-CB797FA734BBQ36353387-B4B2A0B6-3F96-491B-9E63-E8B72919F309
P2860
Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
Partial purification and some ...... A-A2 and a variant of HLA-A28.
@en
Partial purification and some ...... A-A2 and a variant of HLA-A28.
@nl
type
label
Partial purification and some ...... A-A2 and a variant of HLA-A28.
@en
Partial purification and some ...... A-A2 and a variant of HLA-A28.
@nl
prefLabel
Partial purification and some ...... A-A2 and a variant of HLA-A28.
@en
Partial purification and some ...... A-A2 and a variant of HLA-A28.
@nl
P921
P1433
P1476
Partial purification and some ...... A-A2 and a variant of HLA-A28.
@en
P2093
P304
P356
10.1016/0198-8859(81)90065-3
P4510
P577
1981-12-01T00:00:00Z